These findings align, in part, with our prior data (Figure 2, Figure 3 and Figure S8) indicating higher and more significant correlations between the expression of FABP7 and its regulated factors and prognosis and outcomes in LGG patients compared to GBM patients. Here, FABP7 is linked to glioblastoma.